hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling Pathway
Cytotoxic T-lymphocyte-associated protein 4- (CTLA4-) modified human bone marrow-derived mesenchymal stem cells (hBMMSCs) might be promising seed cells for bone tissue engineering. However, the underlying mechanism is not clear. In the present study, we investigated whether CTLA4-modified hBMMSCs ar...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2020/3608284 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566494379114496 |
|---|---|
| author | Lei Song Fei Zhang Rui Zhou Jun Xiao Lei He Fei Dai |
| author_facet | Lei Song Fei Zhang Rui Zhou Jun Xiao Lei He Fei Dai |
| author_sort | Lei Song |
| collection | DOAJ |
| description | Cytotoxic T-lymphocyte-associated protein 4- (CTLA4-) modified human bone marrow-derived mesenchymal stem cells (hBMMSCs) might be promising seed cells for bone tissue engineering. However, the underlying mechanism is not clear. In the present study, we investigated whether CTLA4-modified hBMMSCs are involved in the migration of allogeneic hBMMSCs (allo-hBMMSCs) by maintaining POSTN secretion. hBMMSCs were isolated from different groups, named hBMMSCs and allo-hBMMSCs. hBMMSCs that were infected with the negative control (NC), empty adenovirus- or recombinant adenovirus-expressing CTLA4, POSTN, or CTLA4 plus the shRNA of POSTN were named NC hBMMSCs, CTLA4-modified hBMMSCs, POSTN-modified hBMMSCs, or CTLA4+shPOSTN-modified hBMMSCs, respectively. They were then cocultured with PBMCs in a 1 : 5 ratio with 2.5 μg/mL phytohemagglutinin (PHA). The coculture supernatant was collected to treat allo-hBMMSCs with anti-integrin αvβ3 IgG, or negative control IgG, as a control. Following this, ELISA, Transwell assays, wound healing assays, and western blotting were performed. We found that the POSTN level was higher in the culture supernatant of CTLA4- and POSTN-modified hBMMSCs than in NC hBMMSCs cocultured with PBMCs treated with PHA. The migration capability of allo-hBMMSCs was enhanced, and the integrin αvβ3/FAK/ERK signaling pathway in allo-hBMMSCs was activated by the culture supernatant of CTLA4- and POSTN-modified hBMMSCs cocultured with PBMCs treated with PHA. Additionally, these induced effects can be weakened by POSTN knockdown, and the migration capability of allo-hBMMSCs was blocked by anti-integrin αvβ3 IgG. In conclusion, hCTLA4-gene-modified hBMMSCs maintain POSTN secretion to enhance the migration capability of allogeneic hBMMSCs through the integrin αvβ3/FAK/ERK signaling pathway in the T cell immune activation environment. |
| format | Article |
| id | doaj-art-99b6efc6bd5a4a36aa6668887f818f60 |
| institution | Kabale University |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-99b6efc6bd5a4a36aa6668887f818f602025-02-03T01:04:06ZengWileyStem Cells International1687-966X1687-96782020-01-01202010.1155/2020/36082843608284hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling PathwayLei Song0Fei Zhang1Rui Zhou2Jun Xiao3Lei He4Fei Dai5Department of Orthopaedics, First Affiliated Hospital, Army Medical University, Chongqing 400038, ChinaDepartment of Traumatic Orthopaedics, General Hospital of Xinjiang Military Region, Urumqi 830000, ChinaDepartment of Orthopaedics, First Affiliated Hospital, Army Medical University, Chongqing 400038, ChinaDepartment of Orthopaedics, First Affiliated Hospital, Army Medical University, Chongqing 400038, ChinaDepartment of Orthopaedics, First Affiliated Hospital, Army Medical University, Chongqing 400038, ChinaDepartment of Orthopaedics, First Affiliated Hospital, Army Medical University, Chongqing 400038, ChinaCytotoxic T-lymphocyte-associated protein 4- (CTLA4-) modified human bone marrow-derived mesenchymal stem cells (hBMMSCs) might be promising seed cells for bone tissue engineering. However, the underlying mechanism is not clear. In the present study, we investigated whether CTLA4-modified hBMMSCs are involved in the migration of allogeneic hBMMSCs (allo-hBMMSCs) by maintaining POSTN secretion. hBMMSCs were isolated from different groups, named hBMMSCs and allo-hBMMSCs. hBMMSCs that were infected with the negative control (NC), empty adenovirus- or recombinant adenovirus-expressing CTLA4, POSTN, or CTLA4 plus the shRNA of POSTN were named NC hBMMSCs, CTLA4-modified hBMMSCs, POSTN-modified hBMMSCs, or CTLA4+shPOSTN-modified hBMMSCs, respectively. They were then cocultured with PBMCs in a 1 : 5 ratio with 2.5 μg/mL phytohemagglutinin (PHA). The coculture supernatant was collected to treat allo-hBMMSCs with anti-integrin αvβ3 IgG, or negative control IgG, as a control. Following this, ELISA, Transwell assays, wound healing assays, and western blotting were performed. We found that the POSTN level was higher in the culture supernatant of CTLA4- and POSTN-modified hBMMSCs than in NC hBMMSCs cocultured with PBMCs treated with PHA. The migration capability of allo-hBMMSCs was enhanced, and the integrin αvβ3/FAK/ERK signaling pathway in allo-hBMMSCs was activated by the culture supernatant of CTLA4- and POSTN-modified hBMMSCs cocultured with PBMCs treated with PHA. Additionally, these induced effects can be weakened by POSTN knockdown, and the migration capability of allo-hBMMSCs was blocked by anti-integrin αvβ3 IgG. In conclusion, hCTLA4-gene-modified hBMMSCs maintain POSTN secretion to enhance the migration capability of allogeneic hBMMSCs through the integrin αvβ3/FAK/ERK signaling pathway in the T cell immune activation environment.http://dx.doi.org/10.1155/2020/3608284 |
| spellingShingle | Lei Song Fei Zhang Rui Zhou Jun Xiao Lei He Fei Dai hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling Pathway Stem Cells International |
| title | hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling Pathway |
| title_full | hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling Pathway |
| title_fullStr | hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling Pathway |
| title_full_unstemmed | hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling Pathway |
| title_short | hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling Pathway |
| title_sort | hctla4 gene modified human bone marrow derived mesenchymal stem cells hbmmscs maintain postn secretion to enhance the migration capability of allogeneic hbmmscs through the integrin αvβ3 fak erk signaling pathway |
| url | http://dx.doi.org/10.1155/2020/3608284 |
| work_keys_str_mv | AT leisong hctla4genemodifiedhumanbonemarrowderivedmesenchymalstemcellshbmmscsmaintainpostnsecretiontoenhancethemigrationcapabilityofallogeneichbmmscsthroughtheintegrinavb3fakerksignalingpathway AT feizhang hctla4genemodifiedhumanbonemarrowderivedmesenchymalstemcellshbmmscsmaintainpostnsecretiontoenhancethemigrationcapabilityofallogeneichbmmscsthroughtheintegrinavb3fakerksignalingpathway AT ruizhou hctla4genemodifiedhumanbonemarrowderivedmesenchymalstemcellshbmmscsmaintainpostnsecretiontoenhancethemigrationcapabilityofallogeneichbmmscsthroughtheintegrinavb3fakerksignalingpathway AT junxiao hctla4genemodifiedhumanbonemarrowderivedmesenchymalstemcellshbmmscsmaintainpostnsecretiontoenhancethemigrationcapabilityofallogeneichbmmscsthroughtheintegrinavb3fakerksignalingpathway AT leihe hctla4genemodifiedhumanbonemarrowderivedmesenchymalstemcellshbmmscsmaintainpostnsecretiontoenhancethemigrationcapabilityofallogeneichbmmscsthroughtheintegrinavb3fakerksignalingpathway AT feidai hctla4genemodifiedhumanbonemarrowderivedmesenchymalstemcellshbmmscsmaintainpostnsecretiontoenhancethemigrationcapabilityofallogeneichbmmscsthroughtheintegrinavb3fakerksignalingpathway |